Financials
- Market Capitalization 1.37 B
- Employee 110
- Founded 2024
- CEO N/A
- Website www.inhibrx.com
- Headquarter Delaware, United States
- FIGI BBG01MS5Q9G3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.74
Relación precio/flujo de caja
941.13
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2214 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.28 USD | +1.47% | -6.65% | +20.17% | +55.64% | 1.43 B USD | ||
| 2240 | NVAX Novavax, Inc. - Common Stock | 8.42 USD | -5.50% | -9.27% | -8.68% | +21.68% | 1.38 B USD | ||
| 2302 | ARDX Ardelyx, Inc. - Common Stock | 5.16 USD | +0.39% | -3.19% | -10.10% | +14.16% | 1.27 B USD | ||
| 2310 | CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 14.97 USD | +1.77% | -3.61% | +21.02% | +258.99% | 1.26 B USD |